Our Team

• 

  Jan Kaminski

  Executive Chairman

  Jan brings decades of global growth and leadership experience to the CryoStasis team, including 15 years as President of Colonnade Investments. He’s guided venture-backed start-ups to successful M&As and held several advisory and board positions among a number of corporations and not-for-profits. His experience spans industries including agriculture, enterprise management, medical device technologies and more.

  Read More

  Close

  Jan Kaminski

  Executive Chairman

  Jan brings decades of global growth and leadership experience to the CryoStasis team, including 15 years as President of Colonnade Investments. He’s guided venture-backed start-ups to successful M&As and held several advisory and board positions among a number of corporations and not-for-profits. His experience spans industries including agriculture, enterprise management, medical device technologies and more.

  
• 

  Keith Millar

  Chief Executive Officer

  Keith has been leading teams in various markets and industries for the last 25 years. Keith’s engineering background, MBA and leadership experience yields a powerful mix of business and technology skills. Keith has led teams in Aerospace, Healthcare, IT software & services. Keith has a proven record of successfully aligning company core competencies with customer problems.

  Read More

  Close

  Keith Millar

  Chief Executive Officer

  Keith has been leading teams in various markets and industries for the last 25 years. Keith’s engineering background, MBA and leadership experience yields a powerful mix of business and technology skills. Keith has led teams in Aerospace, Healthcare, IT software & services. Keith has a proven record of successfully aligning company core competencies with customer problems.

  
• 

  Thomas Allen

  Chief Science Officer

  Tom is a physical chemist with an extensive academic and professional background. While doing a postdoctoral fellowship at Ohio State, Tom met his wife, Dr. Olga Kukal. Over the course of three decades, the two founded three biotechnical companies to actualize the transformative potential of Olga’s research. As CSO, Tom honours Olga’s memory by continuing to advance the research she began more than 40 years ago and that, together, they distilled into a life-changing technology.

  Read More

  Close

  Thomas Allen

  Chief Science Officer

  Tom is a physical chemist with an extensive academic and professional background. While doing a postdoctoral fellowship at Ohio State, Tom met his wife, Dr. Olga Kukal. Over the course of three decades, the two founded three biotechnical companies to actualize the transformative potential of Olga’s research. As CSO, Tom honours Olga’s memory by continuing to advance the research she began more than 40 years ago and that, together, they distilled into a life-changing technology.

  
• 

  Photis Loizides

  Chief Medical Officer

  Dr. Photis Loizides is a Plastic and Reconstructive Surgeon at Richmond Hospital and is the founder and operator of a successful Vancouver-based plastic surgery clinic. He is a Clinical Instructor of Surgery at the University of British Columbia. Fully accredited by the Royal College of Physicians and Surgeons, Photis has over a decade of experience performing reconstructive and cosmetic surgical procedures with extensive training in minimizing the effects of ischemic damage on tissues and organs.

  Read More

  Close

  Photis Loizides

  Chief Medical Officer

  Dr. Photis Loizides is a Plastic and Reconstructive Surgeon at Richmond Hospital and is the founder and operator of a successful Vancouver-based plastic surgery clinic. He is a Clinical Instructor of Surgery at the University of British Columbia. Fully accredited by the Royal College of Physicians and Surgeons, Photis has over a decade of experience performing reconstructive and cosmetic surgical procedures with extensive training in minimizing the effects of ischemic damage on tissues and organs.

  
• 

  Chantal Hemens

  Vice President of Operations

  Chantal has over thirty years of combined technical and management experience in the biotech and telecommunications industries. In the past 17 years, she led teams in both small (<50) and medium (>500) size medical device organizations with focus on manufacturing, quality, and regulatory compliance. Chantal provided strategic and tactical leadership for manufacturing medical devices to achieve business critical objectives while meeting global regulatory and quality requirements and exceeding customer expectations. Chantal’s science and operations background, coupled with her passion for leading people, a strong combination with proven results.

  Read More

  Close

  Chantal Hemens

  Vice President of Operations

  Chantal has over thirty years of combined technical and management experience in the biotech and telecommunications industries. In the past 17 years, she led teams in both small (<50) and medium (>500) size medical device organizations with focus on manufacturing, quality, and regulatory compliance. Chantal provided strategic and tactical leadership for manufacturing medical devices to achieve business critical objectives while meeting global regulatory and quality requirements and exceeding customer expectations. Chantal’s science and operations background, coupled with her passion for leading people, a strong combination with proven results.

  
• 

  Sebastian Hadjiantoniou

  Vice President of Research and Development

  Sebastian is a cellular biologist turned entrepreneur. Having completed his masters in neuroscience from Kings College London and Phd in cell biology from the University of Ottawa, his expertise lies in cellular life. He co-founded Incuvers, a hardware biotechnology company whose mission was to connect every researcher around the world in real time. The company raised over $1.5M in pre-seed funding and commercialized their flagship product IRIS in under 30 months. Sebastian’s academic and fast paced startup background brings an interdisciplinary lens and first principles approach to bringing product to market. 

  Read More

  Close

  Sebastian Hadjiantoniou

  Vice President of Research and Development

  Sebastian is a cellular biologist turned entrepreneur. Having completed his masters in neuroscience from Kings College London and Phd in cell biology from the University of Ottawa, his expertise lies in cellular life. He co-founded Incuvers, a hardware biotechnology company whose mission was to connect every researcher around the world in real time. The company raised over $1.5M in pre-seed funding and commercialized their flagship product IRIS in under 30 months. Sebastian’s academic and fast paced startup background brings an interdisciplinary lens and first principles approach to bringing product to market. 

  
• 

  Aaron Del Duca

  Vice President of Business Development

  Aaron Del Duca is a product and business unit leader with over 18 years of experience in medical devices, molecular diagnostics, and SaaS. Aaron excels at identifying market opportunities, developing innovative solutions, and forging strategic partnerships with industry leaders. With a background in molecular biology and a passion for building from zero-to-one, he has consistently driven transformative growth in public and private companies, with a focus on improving predictive and preventive healthcare.

  Read More

  Close

  Aaron Del Duca

  Vice President of Business Development

  Aaron Del Duca is a product and business unit leader with over 18 years of experience in medical devices, molecular diagnostics, and SaaS. Aaron excels at identifying market opportunities, developing innovative solutions, and forging strategic partnerships with industry leaders. With a background in molecular biology and a passion for building from zero-to-one, he has consistently driven transformative growth in public and private companies, with a focus on improving predictive and preventive healthcare.

  
• 

  Jeremy Rutke

  Chief Financial Officer

  Jeremy is an experienced executive with over 15 years of leadership in finance, accounting, and compliance. With his time in the investment finance, real estate and investment management industries, he has a strong functional ability to lead complex initiatives and help businesses achieve their strategic goals. Jeremy completed the accounting program at the Sprott School of Business and worked in Deloitte’s audit practise, where he obtained his CPA, CA designation.

  Read More

  Close

  Jeremy Rutke

  Chief Financial Officer

  Jeremy is an experienced executive with over 15 years of leadership in finance, accounting, and compliance. With his time in the investment finance, real estate and investment management industries, he has a strong functional ability to lead complex initiatives and help businesses achieve their strategic goals. Jeremy completed the accounting program at the Sprott School of Business and worked in Deloitte’s audit practise, where he obtained his CPA, CA designation.